{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/ENVB/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-09T04:44:55.118Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":12449,"canonical_name":"Enveric Biosciences, Inc.","cik":"0000890821","uei":null,"lei":null,"duns":null,"ticker":"ENVB"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":14},"count":14,"timeline":[{"ts":"2026-06-09","kind":"sec.filing","form_type":"8-K","title":"8-K — Enveric Biosciences, Inc. — 2026-06-09","url_slug":"/sec/cik-0000890821/8-k/0001493152-26-027781","accession_number":"0001493152-26-027781","importance":35},{"ts":"2026-06-09","kind":"sec.filing","form_type":"8-K","title":"8-K — Enveric Biosciences, Inc. — 2026-06-09","url_slug":"/sec/cik-0000890821/8-k/0001493152-26-027976","accession_number":"0001493152-26-027976","importance":35},{"ts":"2026-06-09","kind":"sec.filing","form_type":"424B5","title":"424B5 — Enveric Biosciences, Inc. — 2026-06-09","url_slug":"/sec/cik-0000890821/424b5/0001493152-26-027975","accession_number":"0001493152-26-027975","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"S-8","title":"S-8 — Enveric Biosciences, Inc. — 2026-06-01","url_slug":"/sec/cik-0000890821/s-8/0001493152-26-026476","accession_number":"0001493152-26-026476","importance":30},{"ts":"2026-06-01","kind":"sec.insider.a","reporter":"WEBB MICHAEL D","title":null,"shares":18518,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-01","kind":"sec.insider.a","reporter":"PASQUALONE FRANK","title":null,"shares":18518,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-01","kind":"sec.insider.a","reporter":"Schabacker Marcus","title":null,"shares":18518,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-01","kind":"sec.insider.a","reporter":"Kegler George A.","title":null,"shares":18518,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-01","kind":"sec.insider.a","reporter":"Tucker Joseph Edward","title":"Chief Executive Officer","shares":201124,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-01","kind":"sec.insider.a","reporter":"Facchini Peter J.","title":"Chief Innovation Officer","shares":25000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-01","kind":"sec.insider.a","reporter":"Coveney Kevin Michael","title":"Chief Financial Officer","shares":133333,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-01","kind":"sec.insider.a","reporter":"DeWitt Sheila","title":null,"shares":18518,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-15","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Enveric Biosciences, Inc. — 2026-05-15","url_slug":"/sec/cik-0000890821/10-q/0001493152-26-023353","accession_number":"0001493152-26-023353","importance":45},{"ts":"2026-05-15","kind":"sec.filing","form_type":"8-K","title":"8-K — Enveric Biosciences, Inc. — 2026-05-15","url_slug":"/sec/cik-0000890821/8-k/0001493152-26-023345","accession_number":"0001493152-26-023345","importance":35}]}